Search

everythinglearnresearchcommunity

for

Search:↓

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Stem cells from hair follicles can safely treat hair loss.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Early balding linked to higher heart disease risk.

DHT, a testosterone byproduct, causes male pattern baldness.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Genes and hormones cause hair loss, with four genes contributing equally.

New genes found linked to balding, may help develop future treatments.

LLLT promotes hair growth and improves hair density safely in men and women.

Micrografts improve hair density and thickness without side effects.

PRP therapy increases hair density for androgenetic alopecia.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Finasteride effectively treats male hair loss, improving growth and density.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early hair loss may indicate prostate issues.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.